April 1998
SYNTHESIS
(4R,5S)-5-Hydroxy-4-methylhexan-3-one (16):
Analogous to the preparation of compound 9, oxidation of 15 was
done by two different methods.
391
Methyl (2R,3S)-2-Methyl-3-(3,5-dinitrobenzoyloxy)butanoate (13a):
As described for compound 7a, Mitsunobu inversion of 12 (5.7 g,
43 mmol) with Ph3P (22.82 g, 86 mmol), 3,5-dinitrobenzoic acid
(18.46 g, 86 mmol) and DEAD (13.53 mL, 86 mmol) yielded, after
purification, 10.44 g (74%) of 13a as a white solid. GC: capillary col-
umn TRB-1, temp. 250°C, Rt 5.11 min. (single peak), mp 67–68°C;
[a]D23 +12.9 (c = 1, CHCl3).
Method A: From 15 (0.25 g, 1.16 mmol), TEMPO (2 mg,
0.018 mmol), KBr (21 mg, 0.18 mmol), 1.2 M NaOCl (6.6 mL,
8 mmol), 6% HCl (20 mL), KI (0.32 g). After column chromatogra-
phy, 98 mg (65%) of 16 was obtained; bp 50–52°C/1.4 Torr; [a]D21
–30.0 (c = 1.31, Et2O) {Lit7b [a]D21 –30.2 (c = 1.43, Et2O)}.
IR (Neat): n = 3423 (OH), 1708 cm–1 (C=O).
IR (KBr) : n = 1746, 1725 (C=O), 1549, 1347 cm–1 (NO2).
1H NMR: d = 1.27 (d, J = 7.2 Hz, 3 H), 1.41 (d, J = 6.5 Hz, 3 H), 2.83
(dq, J = 7.1 and 5.4 Hz, 1 H), 3.69 (s, 3 H), 5.46 (dq, J = 6.4 and 5.4
Hz, 1 H), 9.07 (d, J = 2.1 Hz, 2 H), 9.17 (t, J = 2.1 Hz, 1 H).
13C NMR: d = 12.23, 17.30, 43.95, 51.97, 73.80, 122.20*, 129.20*,
133.80*, 148.41*, 161.45*, 173.28 (* DNB).
1H NMR: d – 0.95 (t, J = 7.2 Hz, 3 H), 1.04 (d, J = 7.5 Hz, 3 H), 1.05
(d, J = 6.0 Hz, 3 H), 2.34–2.60 (m, 3 H), 3.07 (br s, 1 H), 3.89–4.07
(m, 1 H).
13C NMR: d – 7.59, 10.60, 20.10, 35.39, 51.17, 67.44, 216.37.
Method B: From 15 (0.25 g, 1.16 mmol), oxalyl chloride (0.2 mL,
2.31 mmol), DMSO (0.2 mL, 2.88 mmol), i-Pr2EtN (1 mL,
5.77 mmol), and PPTS (50 mg, 0.2 mmol), 113 mg (75%) of 16 was
obtained.
Anal. calcd. for C13H14N2O8: C, 47.86; H, 4.32; N, 8.59. Found: C,
47.87; H, 4.30; N, 8.61.
Methyl (2R,3S)-3-Hydroxy-2-methylbutanoate (13b):
To a solution of 13a (3 g, 9.19 mmol) in THF/MeOH (25 mL, 4:1)
was added a solution of KOH (0.132 g, 2 mmol) in MeOH (6 mL).
After stirring the mixture for 2 h at 0°C, usual workup and purifica-
tion afforded 1.03 g (85%) of 13b, GC: column TRB-1, temp. 80°C,
Rt 3.98 min (single peak); bp 115–117°C/18 Torr; [a]D25 –13.6 (c =
0.5, MeOH) {Lit23 [a]D25 –13.4 (c = 0.51, MeOH)}.
(1¢S,2¢R)-1¢,2¢-Dimethyl-3¢-oxopentyl (2S,3S)-3-tert-Butyldimeth-
ylsilyloxy-2-methylpentanoate (17):
To a mixture of 3 (0.25 g, 1 mmol) and Et3N (0.16 mL, 1.1 mmol) in
anhyd THF (8 mL) was added 2,6-dichlorobenzoyl chloride
(0.15 mL, 1.1 mmol) under a N2 atmosphere. The mixture was stirred
overnight at r.t. After filtration and removal of the solvent, the residue
was dissolved in anhyd benzene (6 mL). To the mixture were added a
solution of 16 (0.1 g, 0.77 mmol) in anhyd benzene (2 mL) and
DMAP (0.104 g, 0.85 mmol) in benzene (2 mL). The resulting mix-
ture was stirred for 6 h at 0°C and then overnight at r.t. lt was diluted
with Et2O (20 mL), washed with 1M HCl, H2O, aq NaHCO3, brine,
dried (MgSO4) and concentrated in vacuo. The residue was purified
by chromatography on silica gel (hexane/EtOAc, 50:1) to give 0.23 g
(83%) of 17 as a colorless liquid.
IR (Neat): n = 3469 (OH), 1738 cm–1 (C = O).
1H NMR d = 0.92 (d, J = 2.3 Hz, 3 H), 0.95 (d, J = 3.2 Hz, 3 H), 2.24
(dq, J = 7.1 and 5.2 Hz, 1 H), 3.30 (d, J = 5.3 Hz, 1 H), 3.45 (s, 3 H),
3.76 (sext, J = 5.6 Hz, 1 H).
13C NMR: d = 11.31, 19.93, 45.77, 51.19, 67.74, 175.50.
Methyl (2R,3S)-3-Tetrahydropyranyloxy-2-methylbutanoate (13c):
As described for 7c, DHP protection of 13b (2 g, 15.14 mmol) yielded
13c (3.1 g, 95%); bp 91–93°C/1 Torr; [a]D22 +12.1 (c = 1, CHCl3).
IR (Neat): n = 1740 cm–1 (C=O).
1H NMR: d = 1.02 (pseudo t, J = 6.8 Hz, 3 H), 1.08–1.13 (2d, J =
2.9 Hz, 3 H), 1.26–1.73 (m, 6 H, THP), 2.41 (qnt, J = 6.6 Hz, 1 H),
3.24–3.44 (m, 1 H, THP), 3.54 (d, J = 2.2 Hz, 3 H), 3.60–3.99 (m, 2
H, 1 H, THP), 4.45–4.62 (2t, J = 3.2 Hz, 1 H, THP).
IR (Neat): n = 1735 (C=O, ester), 1718 cm–1 (C=O, ketone).
1H NMR: d = 0.01 (s, 3 H), 0.02 (s, 3 H), 0.83 (s, 9H, t, J = 7.3 Hz, 3
H), 0.90–1.20 (m, 12 H), 1.28–1.51 (m, 2 H), 2.36–2.78 (m, 4 H), 3.84
(dq, J = 5.9, 1.2 Hz, 1 H), 5.09 (qnt, J = 6.1 Hz, 1 H).
13C NMR: d = 12.09, 12.45, 16.79, 19.15*, 19.58, 19.71*, 25.30*,
25.37*, 30.72*, 45.21, 45.80, 51.25, 61.80*, 62.52*, 71.28, 75.42,
94.69*, 99.74*, 174.72, 174.79 (* THP).
13C NMR: d = –4.68*, –4.50*, 7.66, 9.40, 11.32, 12.29, 17.72*,
25.65, 25.83*, 35.62, 45.43, 50.44, 71.00, 74.18, 173.52, 211.69
(* TBDMS).
(2S,3S)-2-Methyl-3-tetrahydropyranyloxybutan-1-ol (14):
To a cooled solution (0°C) of LiAlH4 (0.6 g, 15.72 mmol) in anhyd
Et2O (20 mL) was added dropwise a solution of 13c (1.7 g,
7.86 mmol) in Et2O (10 ml). The mixture was stirred for 2 h at 0°C
and then H2O was added (1 mL) followed by 1M NaOH (1 mL) and
stirring was continued for 2 more hours. After filtration and washing
with Et2O, the organic layer was dried (MgSO4) and evaporated
yielding a liquid which upon distillation afforded 1.4 g (94%) of 14;
bp 115–117°C/1.4 Torr; [a]D22 +30.5 (c = 1, CHCl3).
(2S,3R)-2,3-Dihydro-6-[(1¢S,2¢S)-2¢-hydroxy-1¢-methylbutyl]-
2,3,5-trimethyl-4H-pyran-4-one (Stegobiol):
A 1M soln of TiCl4 in CH2Cl2 (3.1 mL, 3.1 mmol) was added drop-
wise at –78°C to a mixture of 17 (0.22 g, 0.6 mmol) and i-Pr2EtN
(0.85 mL, 4.9 mmol) in CH2Cl2 (30 mL). The mixture was stirred at
–78°C for 1 h, then allowed to warm up to –10°C over 2 h and stirred
at that temperature for 20 h. Workup gave a liquid that was taken up
in MeCN (8 mL) and treated with 40% aq HF (10 drops) The mixture
was stirred at 0°C for 10 h, diluted with Et2O, washed with satd aq
NaHCO3 solution and dried (MgSO4). Column chromatography on
silica gel (hexane/Et2O, 2:1) gave pure stegobiol (85 mg, 62%); oil.
GC: column TRB-1, temp. 180°C, Rt 5.19 min. (single peak). [a]D23
–116±5 (c = 0.21, CHCl3) {Lit8a [a]D25 –118±7 (c = 0.107, CHCl3)}.
IR (Neat): n = 3432 (OH), 1661 (C=O), 1600 cm–1 (C=C).
IR (Neat): n = 3425 cm–1 (OH).
1H NMR: d – 0.70–0.77 (2d, J = 5.9Hz, 3 H), 1.0–1.14 (2d, J =
6.5 Hz, 3 H), 1.30–1.90 (m, 7 H, 6 H, THP), 2.99 (br s, 1 H),
3.30–3.65 (m, 3 H, 1 H, THP), 3.69–3.87 (m, 1 H, THP), 3.93 (dq, J
= 6.5, 3.3 Hz, 1 H), 4.38–4.65 (m, 1 H, THP).
13C NMR: d – 10.47, 12.07, 15.95, 17.31, 19.80*, 20.77*, 25.17*,
25.33 *, 30.97*, 31.27*, 39.37, 39.84, 62.70*, 64.18*, 64.90, 72.32,
76.55, 97.82*, 99.11* (* THP).
1H NMR: d = 0.97 (t, J = 7.3 Hz, 3 H), 1.00 (d, J = 7.3 Hz, 3 H), 1.15
(d, J = 7.1 Hz, 3 H), 1.29 (d, J = 5.6 Hz, 3 H), 1.33–1.62 (m, 2 H), 1.72
(s, 3 H), 1.91 (br s, 1 H), 2.34 (dq, J = 7.2 and 3.5 Hz, 1 H), 2.83 (qnt,
J = 6.9 Hz, 1 H), 3.46–3.62 (m, 1 H), 4.46 (dq, J = 6.6 and 3.4 Hz, 1 H).
13C NMR: d = 9.31, 9.51, 10.16, 14.81, 15.97, 28.30, 40.89, 43.71,
75.30, 76.59, 109.22, 172.60, 196.91.
(4S,5S)-5-Tetrahydropyranyloxy-4-methylhexan-3-ol (15):
Swern oxidation of 14 (1.69 g, 9 mmol), using oxalyl chloride
(1.76 mL, 20 mmol), DMSO (1.77 mL, 25 mmol), and i-Pr2EtN
(7.1 mL, 40 mmol), afforded 2.34 g of a liquid that was taken up in
Et2O (20 mL). Addition of a 1M THF soln of EtMgBr (20 mL), workup
and column chromatography (hexane/EtOAc, 12:1) afforded 1.42 g
(73%) of 15; bp 127–129 °C/1.4 Torr; [a]D22 –16.5 (c = 1.06, CHCl3).
IR (Neat): n = 3419 cm–1 (OH).
(2S,3R)-2,3-Dihydro-2,3,5-trimethyl-6-[(R)-1 -methyl-2 -oxobu-
tyl]-4H-pyran-4-one (Stegobinone):
¢
¢
Oxidation of stegobiol was done under Swern conditions. Stegobiol
(0.06 g, 0.25 mmol), oxalyl chloride (0.1 mL, 1 mmol), DMSO
(0.14 mL, 2 mmol), and i-Pr2EtN (0.4 mL, 2.2 mmol) gave after pu-
rification 45 mg (81%) of stegobinone; oil. GC: TRB-1, temp. 180°C,
Rt 4.73 min (single peak). [a]D23 –286±3 (c = 0.53, CHCl3) {Lit7b
[a]D23 –282±10 (c = 0.11, CHCl3)}.
1H NMR: d = 0.67–0.98 (m, 6 H), 1.08–1.80 (m, 11 H, 6 H, THP),
2.90 (br s, 1 H), 3.31–3.56 (m, 2 H, 1 H, THP), 3.56–3.97 (m, 3 H, 1
H, THP), 4.44–4.79 (m, 1 H, THP).
13C NMR: d = 5.11, 6.17, 10.64, 10.73, 17.23, 19.94*, 20.41*,
25.24*, 25.38*, 27.60, 27.95, 31.10*, 31.51*, 41.59, 42.30, 62.92*,
63.58*, 75.83, 76.69, 77.44, 81.63, 95.86*, 100.56* (* THP).
IR (Neat): n = 1720 (C=O), 1665 (C=O, a,b-unsaturated), 1663 cm–1
(C=C).